Per ulteriori informazioni selezionare i riferimenti di interesse.
Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion
NEPHROLOGY DIALYSIS TRANSPLANTATION
Spectrometric determination of silicon in food and biological samples: an interlaboratory trial
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
Increased bone strontium levels in hemodialysis patients with osteomalacia
KIDNEY INTERNATIONAL
Increased serum strontium levels in dialysis patients: An epidemiological survey
KIDNEY INTERNATIONAL
Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients
CLINICAL CHEMISTRY
LOW SERUM ALUMINUM VALUES IN DIALYSIS PATIENTS WITH INCREASED BONE ALUMINUM LEVELS
Clinical nephrology
STRONTIUM CAUSES OSTEOMALACIA IN CHRONIC-RENAL-FAILURE RATS. (VOL 54,PG 448, 1998)
Kidney international
STRONTIUM CAUSES OSTEOMALACIA IN CHRONIC-RENAL-FAILURE RATS
Kidney international
Absorption of silicon in healthy subjects
METAL IONS IN BIOLOGY AND MEDICINE, VOL 5
COMPETITION OF IRON AND ALUMINUM FOR TRANSFERRIN - THE MOLECULAR-BASIS FOR ALUMINUM DEPOSITION IN IRON-OVERLOADED DIALYSIS PATIENTS
Experimental nephrology
ALUMINUM SPECIATION IN CEREBROSPINAL-FLUID OF ACUTELY ALUMINUM-INTOXICATED DIALYSIS PATIENTS BEFORE AND AFTER DESFERRIOXAMINE TREATMENT - ASTEP IN THE UNDERSTANDING OF THE ELEMENTS NEUROTOXICITY
Nephrology, dialysis, transplantation
MEASUREMENT OF STRONTIUM IN SERUM, URINE, BONE, AND SOFT-TISSUES BY ZEEMAN ATOMIC-ABSORPTION SPECTROMETRY
Clinical chemistry
EFFECT OF THE IRON (FE-) STATUS ON SERUM (SE) ALUMINUM (AL) SPECIATION - AL EXPLANATION FOR INCREASED BONE AL LEVELS DESPITE LOW SE-A CONCENTRATIONS
Journal of the American Society of Nephrology
STRONTIUM-INDUCED OSTEOMALACIA - A NEW DISEASE ENTITY IN THE DIALYSISPOPULATION - AN EPIDEMIOLOGIC SURVEY
Journal of the American Society of Nephrology
QUANTITATIVE-DETERMINATION OF TRANSFERRIN IN CEREBROSPINAL-FLUID USING AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY
Fresenius' journal of analytical chemistry
LOW-DOSE (5 MG KG) DESFERRIOXAMINE TREATMENT IN ACUTELY ALUMINUM-INTOXICATED HEMODIALYSIS-PATIENTS USING 2 DRUG ADMINISTRATION SCHEDULES/
Nephrology, dialysis, transplantation
ALUMINUM AND SILICON IN THE HEMODIALYSIS POPULATION OF THE KINGDOM OFSAUDI-ARABIA
Saudi medical journal
DETERMINATION OF IONIZED CALCIUM - EVALUATION OF SAMPLING AND STORAGEPROCEDURES
Clinical chemistry
LOW-DOSE DFO TREATMENT (5 MG KG) IN ACUTELY ALUMINUM-INTOXICATED HEMODIALYSIS (HD) PATIENTS USING 2 DRUG ADMINISTRATION SCHEDULES/
Journal of the American Society of Nephrology
ALUMINUM IN CEREBROSPINAL-FLUID IS NOT BOUND TO TRANSFERRIN
Journal of the American Society of Nephrology
BONE TRACE-METAL ALTERATIONS IN RENAL OSTEODYSTROPHY
Journal of the American Society of Nephrology
INCREASED STRONTIUM LEVELS IN BONE OF DIALYSIS PATIENTS WITH OSTEOMALACIA
Journal of the American Society of Nephrology
ALUMINUM TRANSFERRIN (ALTF) BUT NOT ALCITRATE (ALCIT) UPTAKE BY THE PARATHYROID-GLAND (PTG) MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM ASSOCIATED WITH ADYNAMIC BONE-DISEASE (ABD)
Journal of the American Society of Nephrology
INCREASED SILICON LEVELS IN DIALYSIS PATIENTS DUE TO HIGH-SILICON CONTENT IN THE DRINKING-WATER, INADEQUATE WATER-TREATMENT PROCEDURES, ANDCONCENTRATE CONTAMINATION - A MULTICENTER STUDY
Nephrology, dialysis, transplantation
USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD
Nephrology, dialysis, transplantation
HPLC-AAS HYBRID TECHNIQUE FOR STUDYING THE SPECIATION OF TRACE-METALS(AL, FE, SI, HG) IN BIOLOGICAL-FLUIDS - A REVIEW OF APPLICATIONS, RECENT EXPERIENCES AND PERSPECTIVES
Mikrochimica acta
UPTAKE OF ALUMINUM (AL) BY THE PARATHYROID CELLS (PTC) VIA TRANSFERRIN RECEPTOR (TFR)-MEDIATED ENDOCYTOSIS MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM IN ADYNAMIC BONE-DISEASE (ABD)
Journal of the American Society of Nephrology
VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS
Kidney international
HIGH NONPROTEIN BOUND SERUM SILICON (SESI) LEVELS IN DIALYSIS (D) PATIENTS
Kidney international
URINARY AND BILIARY-EXCRETION OF ALUMINOXAMINE AND FERRIOXAMINE IN DOGS WITH VARIOUS RENAL-FUNCTION
Kidney international
QUANTITATIVE HPLC ETAAS HYBRID METHOD WITH AN ONLINE METAL SCAVENGER FOR STUDYING THE PROTEIN-BINDING AND SPECIATION OF ALUMINUM AND IRON/
Analytical chemistry
NEW INSIGHTS AND STRATEGIES IN THE DIAGNOSIS AND TREATMENT OF ALUMINUM OVERLOAD IN DIALYSIS PATIENTS
Nephrology, dialysis, transplantation